Mucus-penetrating lipid nanoparticles overcome lung barriers for pulmonary co-delivery of siGSDMD and pDNA-SAP in idiopathic pulmonary fibrosis
Fields of Study & Subjects
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Inhalation and Respiratory Drug Delivery
Nanoparticle-Based Drug Delivery
Publication details
- Journal / source
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Volume
- 697
- Pages
- 126878–126878
- Publication date
- 13 April 2026
- Language
- EN